Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch

  • Aspalter, Irene Maria
  • Gordon, Emma
  • Dubrac, Alexandre
  • Ragab, Anan
  • Narloch, Jarek
  • Vizán, Pedro
  • Geudens, Ilse
  • Collins, Russell Thomas
  • Areias Franco, Claudio
  • Abrahams, Cristina Luna
  • Thurston, Gavin
  • Fruttiger, Marcus
  • Rosewell, Ian
  • Eichmann, Anne
  • Gerhardt, Holger
Includes supplementary materials for the online appendix., Sprouting angiogenesis drives blood vessel growth in healthy and diseased tissues. Vegf and Dll4/Notch signalling cooperate in a negative feedback loop that specifies endothelial tip and stalk cells to ensure adequate vessel branching and function. Current concepts posit that endothelial cells default to the tip-cell phenotype when Notch is inactive. Here we identify instead that the stalk-cell phenotype needs to be actively repressed to allow tip-cell formation. We show this is a key endothelial function of neuropilin-1 (Nrp1), which suppresses the stalk-cell phenotype by limiting Smad2/3 activation through Alk1 and Alk5. Notch downregulates Nrp1, thus relieving the inhibition of Alk1 and Alk5, thereby driving stalk-cell behaviour. Conceptually, our work shows that the heterogeneity between neighbouring endothelial cells established by the lateral feedback loop of Dll4/Notch utilizes Nrp1 levels as the pivot, which in turn establishes differential responsiveness to TGF-β/BMP signalling., We are grateful to Dr Guido Serini for provision of Nrp1 expression constructs. We thank Dr Daniel Greif and Dr Teodelinda Mirabella (Yale University) for providing Alk5 floxed mice. We thank Dr Caroline Hill (London Research Institute, CRUK) for her invaluable scientific input and Michael Simons for critical reading of the manuscript. Furthermore, we thank Mary Ann Haskings (Transgenic Services, London Research Institute—Clare Hall Laboratories) for her help in generating chimeric mice. I.M.A. is a recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences at the London Research Institute—Cancer Research UK. C.A.F. is supported by a EU FP7 Marie Curie Post-doctoral Fellowship. This work was supported by Cancer Research UK (H.G.), the EMBO Young Investigator Programme (H.G.), the Lister Institute of Preventive Medicine (H.G.), the ERC starting grant Reshape (311719) (H.G.), the Leducq Transatlantic Network ARTEMIS (H.G. and A.E.), NIH R01 HL 111504-02 (A.E.) and Thome Memorial Foundation (A.E.).
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

PTEN mediates Notch-dependent stalk cell arrest in angiogenesis.

  • Serra, Helena
  • Chivite, Íñigo
  • Angulo Aguado, Ana
  • Soler, Adriana
  • Sutherland, James David
  • Arruabarrena-Aristorena, Amaia
  • Ragab, Anan
  • Lim, Radiance
  • Malumbres, Marcos
  • Fruttiger, Marcus
  • Potente, Michael
  • Serrano Marugán, Manuel
  • Fabra Fres, Àngels
  • Viñals Canals, Francesc
  • Casanovas i Casanovas, Oriol
  • Pandolfi, Pier Paolo
  • Bigas Salvans, Anna
  • Carracedo, Arkaitz
  • Gerhardt, Holger
  • Graupera i Garcia-Milà, Mariona
Coordinated activity of VEGF and Notch signals guides the endothelial cell (EC) specification into tip and stalk cells during angiogenesis. Notch activation in stalk cells leads to proliferation arrest via an unknown mechanism. By using gain- and loss-of-function gene-targeting approaches, here we show that PTEN is crucial for blocking stalk cell proliferation downstream of Notch, and this is critical for mouse vessel development. Endothelial deletion of PTEN results in vascular hyperplasia due to a failure to mediate Notch-induced proliferation arrest. Conversely, overexpression of PTEN reduces vascular density and abrogates the increase in EC proliferation induced by Notch blockade. PTEN is a lipid/protein phosphatase that also has nuclear phosphatase-independent functions. We show that both the catalytic and non-catalytic APC/C-Fzr1/Cdh1-mediated activities of PTEN are required for stalk cells' proliferative arrest. These findings define a Notch-PTEN signalling axis as an orchestrator of vessel density and implicate the PTEN-APC/C-Fzr1/Cdh1 hub in angiogenesis.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

PTEN mediates Notch-dependent stalk cell arrest in angiogenesis.

  • Serra, Helena
  • Chivite, Íñigo
  • Angulo Aguado, Ana
  • Soler, Adriana
  • Sutherland, James David
  • Arruabarrena-Aristorena, Amaia
  • Ragab, Anan
  • Lim, Radiance
  • Malumbres, Marcos
  • Fruttiger, Marcus
  • Potente, Michael
  • Serrano Marugán, Manuel
  • Fabra Fres, Àngels
  • Viñals Canals, Francesc
  • Casanovas i Casanovas, Oriol
  • Pandolfi, Pier Paolo
  • Bigas Salvans, Anna
  • Carracedo, Arkaitz
  • Gerhardt, Holger
  • Graupera i Garcia-Milà, Mariona
Coordinated activity of VEGF and Notch signals guides the endothelial cell (EC) specification into tip and stalk cells during angiogenesis. Notch activation in stalk cells leads to proliferation arrest via an unknown mechanism. By using gain- and loss-of-function gene-targeting approaches, here we show that PTEN is crucial for blocking stalk cell proliferation downstream of Notch, and this is critical for mouse vessel development. Endothelial deletion of PTEN results in vascular hyperplasia due to a failure to mediate Notch-induced proliferation arrest. Conversely, overexpression of PTEN reduces vascular density and abrogates the increase in EC proliferation induced by Notch blockade. PTEN is a lipid/protein phosphatase that also has nuclear phosphatase-independent functions. We show that both the catalytic and non-catalytic APC/C-Fzr1/Cdh1-mediated activities of PTEN are required for stalk cells' proliferative arrest. These findings define a Notch-PTEN signalling axis as an orchestrator of vessel density and implicate the PTEN-APC/C-Fzr1/Cdh1 hub in angiogenesis.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch

  • Aspalter, Irene Maria
  • Gordon, Emma
  • Dubrac, Alexandre
  • Ragab, Anan
  • Narloch, Jarek
  • Vizán, Pedro
  • Geudens, Ilse
  • Collins, Russell Thomas
  • Areias Franco, Claudio
  • Abrahams, Cristina Luna
  • Thurston, Gavin
  • Fruttiger, Marcus
  • Rosewell, Ian
  • Eichmann, Anne
  • Gerhardt, Holger
Includes supplementary materials for the online appendix., Sprouting angiogenesis drives blood vessel growth in healthy and diseased tissues. Vegf and Dll4/Notch signalling cooperate in a negative feedback loop that specifies endothelial tip and stalk cells to ensure adequate vessel branching and function. Current concepts posit that endothelial cells default to the tip-cell phenotype when Notch is inactive. Here we identify instead that the stalk-cell phenotype needs to be actively repressed to allow tip-cell formation. We show this is a key endothelial function of neuropilin-1 (Nrp1), which suppresses the stalk-cell phenotype by limiting Smad2/3 activation through Alk1 and Alk5. Notch downregulates Nrp1, thus relieving the inhibition of Alk1 and Alk5, thereby driving stalk-cell behaviour. Conceptually, our work shows that the heterogeneity between neighbouring endothelial cells established by the lateral feedback loop of Dll4/Notch utilizes Nrp1 levels as the pivot, which in turn establishes differential responsiveness to TGF-β/BMP signalling., We are grateful to Dr Guido Serini for provision of Nrp1 expression constructs. We thank Dr Daniel Greif and Dr Teodelinda Mirabella (Yale University) for providing Alk5 floxed mice. We thank Dr Caroline Hill (London Research Institute, CRUK) for her invaluable scientific input and Michael Simons for critical reading of the manuscript. Furthermore, we thank Mary Ann Haskings (Transgenic Services, London Research Institute—Clare Hall Laboratories) for her help in generating chimeric mice. I.M.A. is a recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences at the London Research Institute—Cancer Research UK. C.A.F. is supported by a EU FP7 Marie Curie Post-doctoral Fellowship. This work was supported by Cancer Research UK (H.G.), the EMBO Young Investigator Programme (H.G.), the Lister Institute of Preventive Medicine (H.G.), the ERC starting grant Reshape (311719) (H.G.), the Leducq Transatlantic Network ARTEMIS (H.G. and A.E.), NIH R01 HL 111504-02 (A.E.) and Thome Memorial Foundation (A.E.).